FIBROGEN INC Quarterly Debt-to-equity in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Fibrogen Inc quarterly Debt-to-equity history and growth rate from Q3 2015 to Q3 2024.
  • Fibrogen Inc Debt-to-equity for the quarter ending September 30, 2024 was -230 %, a 67.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -230 +477 +67.5% Sep 30, 2024
Q2 2024 -267 +1.32K +83.1% Jun 30, 2024
Q1 2024 -331 -4.19K -109% Mar 31, 2024
Q4 2023 -450 -1.31K -152% Dec 31, 2023
Q3 2023 -707 -1.16K -257% Sep 30, 2023
Q2 2023 -1.58K -1.86K -679% Jun 30, 2023
Q1 2023 3.85K +3.63K +1612% Mar 31, 2023
Q4 2022 864 +695 +410% Dec 31, 2022
Q3 2022 450 +318 +242% Sep 30, 2022
Q2 2022 274 +164 +149% Jun 30, 2022
Q1 2022 225 +133 +144% Mar 31, 2022
Q4 2021 169 +84.6 +99.7% Dec 31, 2021
Q3 2021 132 +54.7 +71.1% Sep 30, 2021
Q2 2021 110 +41.5 +60.8% Jun 30, 2021
Q1 2021 92.4 +37.1 +67.1% Mar 31, 2021
Q4 2020 84.8 +32.2 +61.2% Dec 31, 2020
Q3 2020 77 +22.8 +42.1% Sep 30, 2020
Q2 2020 68.3 +6.92 +11.3% Jun 30, 2020
Q1 2020 55.3 -14.7 -21% Mar 31, 2020
Q4 2019 52.6 -19.3 -26.8% Dec 31, 2019
Q3 2019 54.1 -17 -23.9% Sep 30, 2019
Q2 2019 61.4 -3.5 -5.4% Jun 30, 2019
Q1 2019 70 -0.87 -1.23% Mar 31, 2019
Q4 2018 71.9 -12.8 -15.1% Dec 31, 2018
Q3 2018 71.2 -37.4 -34.4% Sep 30, 2018
Q2 2018 64.9 -103 -61.3% Jun 30, 2018
Q1 2018 70.9 -105 -59.7% Mar 31, 2018
Q4 2017 84.8 -81.3 -48.9% Dec 31, 2017
Q3 2017 109 -49.4 -31.3% Sep 30, 2017
Q2 2017 168 +21.4 +14.7% Jun 30, 2017
Q1 2017 176 +43.1 +32.4% Mar 31, 2017
Q4 2016 166 +41.6 +33.4% Dec 31, 2016
Q3 2016 158 +43.3 +37.8% Sep 30, 2016
Q2 2016 146 Jun 30, 2016
Q1 2016 133 Mar 31, 2016
Q4 2015 124 Dec 31, 2015
Q3 2015 115 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.